CD200 and psoriasis: We have previously shown that the ligand CD200 is reduced in nonlesional psoriatic skin17 and we therefore hypothesized that in healthy skin, CD200R1 signaling prevents inappropriate inflammation; however, in psoriasis, this is reduced, contributing to psoriasis susceptibility.